A long-term, open-label extension study to investigate the long-term safety of alogliptin in subjects with type 2 diabetes

被引：0
|
作者：
Smith, N. [1 ]
Pratley, R. [2 ]
Wilson, C. [1 ]
Mekki, Q. [1 ]
机构：
[1] Takeda Global Res & Dev Ctr Inc, Deerfield, IL USA
[2] Florida Hosp, Translat Res Inst Diabet & Metab, Orlando, FL USA
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
780
引用
收藏
页码：S357 / S358
页数：2
相关论文
共 50 条
  • [1] Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study
    Tomoya Mita
    Naoto Katakami
    Hidenori Yoshii
    Tomio Onuma
    Hideaki Kaneto
    Takeshi Osonoi
    Toshihiko Shiraiwa
    Tetsuyuki Yasuda
    Yutaka Umayahara
    Tsunehiko Yamamoto
    Hiroki Yokoyama
    Nobuichi Kuribayashi
    Hideaki Jinnouchi
    Masahiko Gosho
    Iichiro Shimomura
    Hirotaka Watada
    [J]. Scientific Reports, 13
  • [2] Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study
    Mita, Tomoya
    Katakami, Naoto
    Yoshii, Hidenori
    Onuma, Tomio
    Kaneto, Hideaki
    Osonoi, Takeshi
    Shiraiwa, Toshihiko
    Yasuda, Tetsuyuki
    Umayahara, Yutaka
    Yamamoto, Tsunehiko
    Yokoyama, Hiroki
    Kuribayashi, Nobuichi
    Jinnouchi, Hideaki
    Gosho, Masahiko
    Shimomura, Iichiro
    Watada, Hirotaka
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] Long-term safety of zonisamide in children with epilepsy: A multicentre, open-label extension study
    Rosenfeld, W.
    Glauser, T.
    Levisohn, P.
    Frank, L. M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 89 - 89
  • [4] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
  • [5] Long-term safety of deutetrabenazine for the treatment of tardive dyskinesia: Results from an open-label, long-term study
    Anderson, K.
    Stamler, D.
    Davis, M.
    Factor, S.
    Hauser, R.
    Isojarvi, J.
    Jarskog, L.
    Jimenez-Shahed, J.
    Kumar, R.
    Ochudlo, S.
    Ondo, W.
    Fernandez, H.
    [J]. MOVEMENT DISORDERS, 2017, 32
  • [6] LONG-TERM PERAMPANEL USE IN OPEN-LABEL EXTENSION STUDIES
    Rektor, Ivan
    Krauss, Gregory L.
    Inoue, Yushi
    Kaneko, Sunao
    Williams, Betsy
    Patten, Anna
    Bibbiani, Francesco
    Laurenza, Antonio
    Wechsler, Robert T.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A23 - A23
  • [7] Long-term safety of brodalumab in Japanese patients with plaque psoriasis: An open-label extension study
    Yamaguchi, Yukie
    Takatsu, Nobumichi
    Ootaki, Kenji
    Nakagawa, Hidemi
    [J]. JOURNAL OF DERMATOLOGY, 2020, 47 (06): : 569 - 577
  • [8] Safety of long-term use of linezolid: results of an open-label study
    Vazquez, Jose A.
    Arnold, Anthony C.
    Swanson, Robert N.
    Biswas, Pinaki
    Bassetti, Matteo
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1347 - 1354
  • [9] Long-term treatment with zonisamide: Results of a 2 year open-label extension study
    Wroe, S.
    Duncan, R.
    [J]. EPILEPSIA, 2006, 47 : 138 - 138
  • [10] Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: An open-label extension study
    Garber, AJ
    Bruce, S
    Fiedorek, FT
    [J]. CLINICAL THERAPEUTICS, 2002, 24 (09) : 1401 - 1413
12345